Table 1.
General characteristics of included records, with the number and per cent of overall publications
| Characteristic | N = 99 | % | Appendix S1: Technical appendix reference[Link] |
|---|---|---|---|
| Publication year | |||
| 2012 | 0 | 0.0 | |
| 2013 | 11 | 11.1 | 1–11 |
| 2014 | 27 | 27.3 | 11–29 |
| 2015 | 17 | 17.2 | 30–46 |
| 2016 | 26 | 26.3 | 11, 47–61 |
| 2017 | 18 | 18.2 | 11, 62–74 |
| Publication type | |||
| Scientific journal article | 71 | 71.7 | 1–10, 12–15, 17–26, 28–74 |
| Conference proceeding | 2 | 2.0 | 16, 27 |
| OIE report | 26 | 26.3 | 11 |
| Other (government reports, etc.) | 0 | 0.0 | |
| Study type | |||
| Observational | 90 | 90.9 | |
| Cross‐sectional | 51 | 51.5 | 1–10, 12, 14–17, 20, 21, 23–27, 29–36, 38–42, 44, 47, 51, 53, 56, 58, 59, 63, 65–72 |
| Longitudinal | 8 | 8.1 | 12, 22, 35, 37, 48, 61, 63, 73 |
| Outbreak investigation | 28 | 28.3 | 11, 13, 52 |
| Other | 6 | 6.1 | 18, 19, 43, 45, 46, 60 |
| Experimental | 9 | 9.1 | |
| Challenge only | 5 | 5.1 | 28, 50, 54, 57, 64 |
| Challenge with transmission | 2 | 2.0 | 55, 57 |
| Vaccine with challenge | 2 | 2.0 | 49, 62 |
| Vaccine without challenge | 1 | 1.0 | 74 |
| Journal | |||
| Emerging Infectious Diseases | 27 | 27.3 | 1, 2, 5, 7, 15, 19, 20, 22–26, 28–30, 35, 37, 38, 46, 47, 51, 53–55, 61, 64, 68 |
| Eurosurveillance | 10 | 10.1 | 3, 9, 10, 17, 21, 39, 44, 45, 69, 70 |
| Emerging Microbes and Infections | 5 | 5.1 | 40, 43, 60, 63, 73 |
| Virus Genes | 3 | 3.0 | 8, 31, 52 |
| EMPRES‐i | 26 | 26.3 | 11 |
| Other[Link] | 28 | 28.3 | 4, 6, 12–14, 16, 18, 27, 32–34, 36, 41, 42, 48–50, 56–59, 62, 65–67, 71, 72, 74 |
Each OIE MERS‐CoV animal event entered in EMPRES‐i was treated as a separate record in the review, but were included under one bibliographic entry, per FAO citation protocol.
Other journals included Epidemiology and Infection; Infection Ecology and Epidemiology; Infection Genetics and Evolution; Japanese Journal of Infectious Diseases; Journal of Veterinary Medicine and Animal Health; Journal of Virology; MBIO; NEJM; One Health; PLOS One; Science China; Scientific Reports; American Journal of Tropical Medicine and Hygiene; The Lancet Infectious Diseases; Transboundary and Emerging Diseases; Vaccine; Vector‐borne and Zoonotic Diseases; Virology Journal; Virus Genes; Science; Viruses.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.